annual meeting & postgraduate course
TRANSCRIPT
Naspghan Registration Brochure :Layout 1NOVEMBER 12–14, 2009
NATIONAL HARBOR, MD
Dear Colleague: We invite you to attend The NASPGHAN Annual Meeting & Postgraduate Course to be held at the beautiful Gaylord National Hotel in National Harbor, MD from Thursday through Saturday November 12th –14th, 2009. The planning committee, including B Li, John Barnard, John Pohl, Steven Schwarz, Alan Leichtner, David Rudnick, Mitch Shub and Kathy Schwarz, has put together an outstanding program that will engage the interest of clinicians, academics, and trainees alike.
The NASPGHAN meeting will begin on Thursday November 12th, 2009 with the annual NASPGHAN Postgraduate Course. We will review a broad spectrum of pediatric gastrointestinal physiology and disease, testing, and treatment modalities. Five topics will be available for this year’s course including obesity management, advances in pediatric hepatobiliary disease, gastrointestinal inflammation, treatment of functional abdominal pain, and new diagnostic testing. Fifteen speakers from North America who are experts in pediatric gastroenterology will present in-depth discussions of these subjects, and we will have one-hour learning lunches in which these speakers will present patient cases.
The main portion of the NASPGHAN meeting begins the evening of Thursday November 12th with a poster session and reception and concludes Saturday evening with a social event. An outstanding and diverse faculty has been assembled for the meeting which will include two distinguished invited speakers: Dr. Preston Campbell of the Cystic Fibrosis Foundation and Dr. Stephen James, Director of the NIDDK, state-of-the-art, year-in-review formats (for both clinical and basic science), 6 research abstract oral presentations and 3 poster sessions (covering basic science, clinical investigation, and clinical practice vignettes and including oral presentations of 6 Posters of Distinction on Friday and Saturday), four concurrent clinical modules will include two new initiatives: a “virtual” Hepatitis B session with 5 small discussion groups and a multi-disciplinary team approach to the management of intestinal failure. The clinical modules have been redesigned to include a 30-minute case-based panel and audience discussion.
Indeed, this year’s NASPGHAN Meeting will be a fabulous event, sure to meet the multiple clinical, research and training needs of our diverse membership.
We look forward to seeing you in our nation’s capital!
Cordially,
B Li, MD Kathleen Schwarz, MD President, NASPGHAN President-Elect, NASPGHAN
ORGANIZING COMMITTEE B Li, MD (NASPGHAN President) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Program Advisor
David Gremse, MD (NASPGHAN Secretary-Treasurer) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Meeting budget
Sandeep Gupta, MD (Professional Education Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Postgraduate Course, Co-Director
Alan Leichtner, MD (Chair, Training Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Teaching and Tomorrow Program
Jenifer Lightdale, MD (Chair, Endoscopy Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Video Learning Center
NASPGHAN National Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Meeting oversight, logistics, planning
John Pohl, MD (Chair, Professional Education Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Postgraduate Course, Co-Director
David Rudnick, MD (Chair, Research Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Annual Meeting
Kathleen Schwarz, MD (NASPGHAN President-Elect) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Program Committee Chair
Steven Schwarz, MD (Chair, Clinical Care & Quality Committee) . . . . Clinical Practice Forum, Clinical Vignette Posters, Billing & Coding
Mitchell Shub, MD (Chair, Professional Development Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Annual Meeting
Located just eight miles due south of Washington, DC, with convenient access to three major airports, the resort hotel is just 15 minutes away from our nation's capital. Located in National Harbor, Maryland in Prince George's County, Gaylord National offers its guests convenient access to Washington, DC with an hourly shuttle service, water taxi to Old Town Alexandria, and shuttle service to Ronald Reagan National Airport.
HOTEL INFORMATION
GAYLORD NATIONAL® Convention Center 201 WATERFRONT STREET NATIONAL HARBOR, MD 20745
HOTEL RESERVATIONS
Single/Double $239.00 + $15.00 Daily Resort Fee* *Includes: in-room high speed internet access, local phone calls up
to 20 minutes, wireless internet access in atrium, lobby & restaurants, toll-free phone calls up to 20 minutes, access to fitness center, two bottled waters in guest room daily and a daily newspaper.
Special NASPGHAN room rate. Applicable taxes will be added. (US rate subject to change based on current exchange rates)
Check-in Time 3:00pm
Check-out Time 12:00noon
To obtain the special NASPGHAN room rates, register ONLINE via the NASPGHAN website:
www.naspghan.org
REGISTRATION The DEADLINE for Early Bird Registration is August 1, 2009
To receive Early-Bird rates and submitting payment by check, envelope must be postmarked no later than August 1, or standard rates will apply.
After August 1st, Standard Rates are applicable. Fees for Postgraduate Course and Annual Meeting will increase by $50 per category.
The DEADLINE for Standard Registration is September 14, 2009
To receive Standard rates and submitting payment by check, envelope must be postmarked no later than September 14, 2009, or On-site registration rates will apply.
After September 14th, On-site Rates are applicable. Fees for Postgraduate Course and Annual Meeting will increase by $50 per category.
Register by mail, fax or Internet. Visit www.naspghan.org to register online. Alternately, mail or fax the registration form located on pages 15–17 of this brochure to the NASPGHAN National Office. Meeting confirmations, tickets and badges will be mailed 3 weeks prior to the meeting.
MEETING OBJECTIVES AND CME INFORMATION Mission Statement
The education mission of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition is to:
Advance understanding of normal development, physiology and pathophysiology of diseases of the gastrointestinal tract, liver and nutrition in children.
Improve professional competence, quality of care, and patient outcomes by disseminating knowledge through scientific meetings, professional and public education.
Our activities, education, and interventions will strive to use Adult Learning Methods (ALM) designed to improve competence, practice performance, and patient outcomes in measurable ways. These educational activities will be targeted to board certified or board eligible pediatric gastroenterologists, physicians with an expertise in pediatric gastroenterology, hepatology and nutrition, subspecialty fellows in pediatric gastroenterology, and nurses specializing in pediatric gastroenterology, hepatology and nutrition.
CME INFORMATION NASPGHAN is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NASPGHAN designates this educational activity for a maximum of 27.25 AMA PRA Category 1 Credit(s) TM. (7.25 credit hours for the Postgraduate Course and 20.0 credit hours for the Annual Meeting). Physicians should only claim credit commensurate with the extent of their participation in the activity.
FACULTY DISCLOSURE In order to ensure independence, objectivity and scientific rigor in all activities and in accordance with the ACCME, ANCC and ACPE Standards for Commercial Support, all those in a position to control the content of an educational activity are required to disclose their relevant financial relationships. This includes indicating that one has nothing to disclose. Disclosure information will be distributed to the activity attendees.
AMERICANS WITH DISABILITIES ACT In compliance with the Americans with Disabilities Act of 1990, NASPGHAN will make all reasonable effort to accommodate persons with disabilities. Contact NASPGHAN in order to make arrangements.
NASPGHAN National Office PO Box 6 Flourtown, PA 19031
Telephone: 215-233-0808 Fax: 215-233-3918 Email: [email protected] Website: www.naspghan.org
8:00am–8:10am INTRODUCTION
Course Directors: John Pohl MD and Sandeep Gupta MD
8:10am–9:20am MODULE A – Obesity: What Can We Do In The Office?
Moderators: John Pohl MD and Kathy Chen MD
Evaluating obesity: Where do I start? Ann Scheimann MD, Johns Hopkins School of Medicine
LEARNING OBJECTIVES:
1. Discuss how the obese child should be evaluated for complications in the office setting, including the use of laboratory testing 2. Define metabolic syndrome and its instability as a diagnosis 3. Discuss current trials and possible use of medication, combined with lifestyle change, including metformin and
thiazolidinediones for treatment of steatohepatitis in association with metabolic syndrome
Increasing activity: What can we do? Sarah Barlow MD, Texas Children’s Hospital
LEARNING OBJECTIVES:
1. Summarize the determinants of increasing patient activity, including behavior change and family-based changes 2. Discuss the role of city/community exercise programs and exercise camps in obesity management 3. Outline billing and insurance aspects regarding these methods of weight reduction
Behavioral therapy and obesity Joseph Skelton MD, Wake Forest University
LEARNING OBJECTIVES:
1. Discuss the role of behavioral modification in obesity management and include strategies to improve clinician-family interaction 2. Review the effectiveness of group visits to treat pediatric obesity 3. Describe other psychological tools, including motivational interviewing and readiness for change assessment
9:10am–9:20am Rapid Fire Questions
9:20am–10:30am MODULE B – Advances in Pediatric Liver Disease: How Do We Interpret the Data?
Moderators: John Pohl MD and Vicky Ng MD
Alagille syndrome: Update Binita Kamath MD, Children’s Hospital of Philadelphia
LEARNING OBJECTIVES:
1. Define Alagille syndrome and update the extra-hepatic manifestations of this syndrome 2. Discuss genetic testing and potential pre-natal testing for Alagille syndrome, including JAG1 and NOTCH2 mutations 3. Review the potential role of cholestatic disease research consortia in the development of future diagnostic testing and therapy
4
Mitochondrial liver disease: Amping up the liver Ronald Sokol MD, University of Colorado
LEARNING OBJECTIVES:
1. Discuss the clinical presentations and genetics, including extra-hepatic involvement, of mitochondrial liver disease 2. Review current testing techniques (serum, hepatic tissue, muscle tissue, CNS imagine, DNA testing, etc.) for mitochondrial
liver disease 3. Discuss pros and cons of liver transplantation in mitochondrial diseases
Primary sclerosing cholangitis: Update Girish Subbarao MD, Indiana University
LEARNING OBJECTIVES:
1. Discuss the pathophysiology of PSC and review its extra-hepatic manifestations 2. Discuss the diagnosis of PSC, including liver biopsy, MRCP, and ERCP, especially using these modalities to differentiate PSC
from autoimmune hepatitis 3. Discuss PSC treatment, including high dose versus standard dose ursodeoxycholic acid and liver transplantation
10:20am–10:30am Rapid Fire Questions
10:30am–10:50am BREAK
10:50am–12:00pm MODULE C – Gastrointestinal Inflammation: What is the Natural History of Disease?
Moderators: Sandeep Gupta MD and Miriam Vos MD
Eosinophilic esophagitis: making the eosinophils go away Richard Noel MD, Medical College of Wisconsin
LEARNING OBJECTIVES:
1. Discuss the data available regarding the number of eosinophils per high power field as it relates to treatment 2. Discuss treatment of the pediatric patient in which eosinophilic esophagitis is found incidentally 3. Discuss the natural history of eosinophilic esophagitis as the pediatric patient progresses to adulthood
H. pylori: Should it always be eradicated? Nicola Jones MD, The Hospital for Sick Children, Toronto
LEARNING OBJECTIVES:
1. Discuss the treatment of a child with functional abdominal pain symptoms in which H. pylori is found incidentally 2. Discuss when H. pylori infection should undergo re-testing after a trial of eradication 3. Discuss how a child with H. pylori should be treated if there is no response to therapy
Inflammatory bowel disease and inflammatory markers Aleixo Muise MD, The Hospital for Sick Children, Toronto
LEARNING OBJECTIVES:
1. Discuss what inflammatory markers are associated with severe IBD in children 2. Discuss when genetic mutation testing should be used in children with IBD and discuss potential future genetic testing 3. Discuss if inflammatory markers can change with therapy or with mucosal healing
11:50am–12:00pmRapid Fire Questions
Session 1: Obesity and behavioral therapy
Moderator: Valeria Cohran MD Joseph Skelton MD
Session 2: Primary sclerosing cholangitis/ Elastometry and liver disease
Moderator: Judy O’Connor MD Girish Subbarao MD and Marilyn Siegel MD
Session 3: Alagille syndrome / Mitochondrial liver disease
Moderator: Vicky Ng MD Binita Kamath MD and Ronald Sokol MD
Session 4: Eosinophilic esophagitis / H. pylori infection
Moderator: Miriam Vos MD Richard Noel MD and Nicola Jones MD
Session 5: Biomarkers in IBD / MRI in gastrointestinal disease
Moderator: Kevin Kelly MD Aleixo Muise MD and Ghassan Wahbeh MD
Session 6: Hypnotherapy in irritable bowel syndrome / Inflammation in irritable bowel syndrome
Moderator: Eyad Hanna MD Miranda Van Tilburg PhD and Robert Shulman MD
Session 7: Metabolic syndrome and pharmacology / Exercise and obesity
Moderator: Kathy Chen MD Ann Scheimann MD and Sarah Barlow MD
Session 8: Impedance monitoring / New medical therapies for constipation
Moderator: Melanie Greifer MD Rachel Rosen MD and Rina Sanghavi MD
1:50pm–3:00pm MODULE D – Treatment of Functional Abdominal Pain
Moderators: John Pohl MD and Eyad Hanna MD
Hypnotherapy and irritable bowel syndrome Miranda Van Tilburg PhD, University of North Carolina
LEARNING OBJECTIVES:
1. Discuss how hypnotherapy is a potential therapy for childhood IBS and discuss what specific hypnotherapy techniques can be utilized
2. Discuss the long-term outcome of hypnotherapy as treatment for IBS 3. Review the clinical evidence that hypnotherapy is a potential therapy for childhood IBS as well as an adjunctive use with
medication
6
Irritable bowel syndrome and inflammation Robert Shulman MD, Texas Children’s Hospital
LEARNING OBJECTIVES:
1. Discuss the theorized pathogenesis of inflammation in IBS 2. Discuss studies that have shown a potential association of intestinal inflammation with IBS 3. Discuss antibiotic treatment options for IBS, in the setting of the potential for bacterial overgrowth
New medical therapies for constipation Rina Sanghavi MD, UT-Southwestern
LEARNING OBJECTIVES:
1. Discuss the use of lubiprostone for the treatment of constipation 2. Discuss the potential use of bile acid therapy for treatment of constipation 3. Discuss the potential use of pre- and probiotics for the treatment of constipation
2:50pm–3:00pm Rapid Fire Questions
3:00pm–3:20pm BREAK
3:20pm–4:30pm MODULE E – New Diagnostic Modalities for Gastrointestinal Disease
Moderators: Sandeep Gupta MD and Melanie Greifer MD
Impedance monitoring for GERD Rachel Rosen MD, Children’s Hospital, Boston
LEARNING OBJECTIVES:
1. Discuss how impedance monitoring works and how it can be combined with esophageal pH testing 2. Discuss how impedance techniques can be used in evaluation of esophageal swallowing function 3. Discuss the pediatric data available regarding esophageal impedance studies
Elastometry imaging techniques of the liver Marilyn Siegel MD, Washington University, St. Louis
LEARNING OBJECTIVES:
1. Discuss how elastometry is utilized in imaging as an alternative to liver biopsy 2. Discuss the use of elastometry compared to other invasive or non-invasive biomarkers in the diagnosis of fibrosis/cirrhosis 3. Discuss the use of elastometry in the evaluation of specific liver diseases, such as NAFLD or liver disease associated with
congenital heart disease
LEARNING OBJECTIVES:
1. Review the advantages and disadvantages of MRI compared to other types of abdominal imaging 2. Discuss medical radiation exposure and its associated effects in children with IBD and how this risk is alleviated with MRI 3. Discuss how MRI can be used to diagnose intestinal/pelvic disease, including inflammatory bowel disease and its complications
4:20pm–4:30pm Rapid Fire Questions
7
5:00pm–7:00pm Welcome Reception/Poster Session I
Friday, November 13, 2009 7:00am–8:00am Meet the Professor Breakfasts (registration required)
1 Developmental biology research and pediatric gastrointestinal diseases Robert Heukeroth MD,Washington University and Alan Mayer MD, Medical College of Wisconsin
2 Treatment of HCV Jean Molleston MD, Indiana University and Girish Subbaro MD, Indiana University
3 The difficult IBD patient Carmen Cuffari MD, Johns Hopkins School of Medicine and Ryan Carvalho MD, Nationwide Children's Hospital
4 Liver Disease in Inflammatory Bowel Disease Dennis Black MD, Le Bonheur Children's Hospital and Tamir Miloh MD, Mt. Sinai School of Medicine
5 Controversies in nutrition Maria Mascarenhas MD, Children’s Hospital of Philadelphia and Susanna Huh MD, Children’s Hospital, Boston
6 Functional Abdominal Pain: How much testing is really needed? Samuel Nurko MD, MPH, Children’s Hospital Boston and Bruno Chumpitazi MD, Texas Children’s Hospital
7 The GERD eQipp module and maintenance of certification Jenifer Lightdale MD, Children’s Hospital Boston and Suzanne Nelson MD, Northwestern University
7:00am–8:30am Clinical trials in pediatric gastroenterology
Patricia Robuck PhD, National Institute of Diabetes and Digestive and Kidney Diseases
8:30am–10:00am Plenary Session I
Basic Science: Year in Review Eric Sibley MD, Stanford University, Editor, JPGN
Award winning abstract presentations
Keynote Address–Building the CF Foundation Therapeutics Development Program: Lessons Learned Preston Campbell MD, Executive Vice President for Medical Affairs, Cystic Fibrosis Foundation, Bethesda, MD
10:00am–10:30am Break
10:30am–12:00pm Concurrent Session I
A Virtual Hepatitis B Moderators: Maureen Jonas MD, Karen Murray MD, Michael Narkewicz MD, Barbara Haber MD, Regino Gonzalez-Peralta MD
Treatment of Hepatitis B Kathleen Schwarz MD, Johns Hopkins School of Medicine
New Format–Kathy Schwarz will present a talk on the treatment of children with hepatitis B. In order to facilitate small group discussion the talk will be broadcast into 5 small rooms to accommodate up to 30 persons each. A moderator skilled in the treatment of hepatitis B, will lead a question and answer session related to the virtual presentation. This is an experiment so feedback is encouraged!
B Pancreatitis Moderators: Peter Durie MD and Sohail Husain MD
Pancreatitis in childhood: Why, oh why? Veronique Morinville MD, Montreal Children's Hospital
Acute pancreatitis: Dogmas and myths Mark Lowe MD, Children's Hospital of Pittsburgh of UPMC
Chronic pancreatitis: Roadblocks on the long and windy road Patrick Okolo MD, Johns Hopkins University
C Research Interest Group/Oral Abstract Presentations Moderators: Robert Heukeroth MD and Elyanne Ratcliffe MD
Can Hirschsprung disease be prevented? New ideas from basic research Robert Heukeroth MD, Washington University
12:15pm–2:15pm Poster Session II
2:30pm–4:00pm Concurrent Session II
A Acute Liver Failure Moderators: Will Treem MD and Kathleen Campbell MD
Recognition/referral Robert Squires MD, Children's Hospital of Pittsburgh of UPMC
Management Philip Rosenthal MD, University of California, San Francisco
Outcomes Estella Alonso MD, Children's Memorial Hospital, Chicago
B Gastrointestinal bleeding in pediatric patients: Why it happens and how to make it stop Moderators: Marsha Kay MD and Mark Gilger MD
Etiologies of GI bleeding in children Jenifer Lightdale MD, Children’s Hospital, Boston
Medical management for upper gastrointestinal bleeding Khalid Khan MD, University of Minnesota
Endoscopic therapy for UGI bleeding Douglas Fishman MD, Texas Children’s Hospital
C Oral Abstract Presentations
Moderators: Steve Schwarz MD and Ian Leibowitz MD
Productivity and performance in pediatric GI practice: A view from the dentist's chair Speakers: Michael Hart MD, Kathleen Mueller and Robert Squires MD
6:00pm–8:00pm Training Program Directors Meeting
Saturday, November 14, 2009
7:00am–8:00am Meet the Professor Breakfasts (Registration Required)
1 Translational research in pediatric gastroenterology James Heubi MD Cincinnati Children’s Hospital & Medical Center and Glenn Furuta MD, The Children’s Hospital, Denver
2 Psychological issues of IBD Eva Szigethy MD, PhD, Children’s Hospital, Boston and Christine Karkowski MD, Children's Hospital of Pittsburgh of UPMC
3 Food allergy Philip Putnam MD, Cincinnati Children’s Hospital & Medical Center and J Pablo Abonia MD, Cincinnati Children’s Hospital & Medical Center
4 GI infections Michael Farrell MD, Cincinnati Children’s Hospital & Medical Center and Sean Moore MD, Vanderbilt Children’s Hospital
5 Endoscopic research Bradley Barth MD, Children’s Medical Center of Dallas and Tom Lin MD, Duke University Medical Center
6 Animal models of inflammatory bowel disease Ted Denson MD Cincinnati Children’s Hospital & Medical Center and Edwin De Zoeten MD, Children’s Hospital of Philadelphia
7:00am–8:30am IBD research: A guide for fellows and junior faculty
1 Subra Kugathasan MD, Emory University
2 Ying Lu MD, Children’s Hospital, Boston
3 Athos Bousvaros MD, Children’s Hospital, Boston
4 Michael Kappelman MD, University of North Carolina
5 Marjorie Merrick, Crohn's & Colitis Foundation of America
6 Sandra Kim MD, Crohn's & Colitis Foundation of America
10
8:30am–10:00am Plenary Session II
Clinical Science: Year in Review William Balistreri MD, Cincinnati Children’s Hospital and Medical Center, Editor, Pediatrics
Maintenance of Certification and Quality Improvement Chris Dickinson MD, American Board of Pediatrics Richard Colletti MD, Trailblazer Improvement Collaborative
Oral Abstract Presentations
Moderators: Harpreet Pall MD and Leo Heitlinger MD Kathleen Mueller
10:00am–12:00pm Poster Session III
12:00pm–2:00pm Annual Business Meeting/Lunch
Keynote Address–NIDDK Support of Research in Pediatric Gastroentology, Hepatology and Nutrition Stephen James MD, Director of The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2:00pm–3:30pm Concurrent Session III
A Guidelines Moderators: Steven Schwarz MD and Pamela Brown MD
Probiotics David Mack MD, Children's Hospital of Eastern Ontario
Neurodevelopmental Kay Motil MD, Baylor University
Skeletal health and IBD Helen Pappas MD, Children’s Hospital, Boston
B Intestinal Failure: The importance of a team approach to problem solving from intestinal rehabilitation to transplantation and beyond Moderator: Stuart Kaufman MD
Intestinal Rehabilitation Surgeon Alfred Chahine MD, Georgetown University School of Medicine
Nurse Coordinator Jill I. Robinson RN, BSN, PNP, Georgetown University School of Medicine
Nutritionist Paige Parady RD, Georgetown University School of Medicine
Pediatric Gastroenterologist Team Leader Stuart S. Kaufman MD, Georgetown University School of Medicine
Social Worker Carrie Potoff MSW, LICSW, Georgetown University School of Medicine
Surgical Nurse Coordinator Martha Kossairas RN, BSN, Georgetown University School of Medicine
Transplant Surgeon Cal S. Matsumoto MD
C Oral Abstract Presentations
3:45pm–5:15pm Concurrent Session IV
A IBD – Biologics Moderators: Athos Bousvaros MD and Maria Oliva–Hemker MD
TNF Inhibitors: Update on efficacy and safety Wallace Crandall MD, Nationwide Children’s Hospital
When should you consider early use of biologics? Joel Rosh MD, Goryeb Children’s Hospital
Beyond TNF Inhibitors: New biologics and the new wave of IBD therapeutics Robert Baldassano MD, Children’s Hospital of Philadelphia
B Celiac Disease Moderators: Alan Leichtner MD and Murali Jatla MD
Diagnosis/Markers Ivor Hill MD, Wake Forest University
Long term complications Ed Hoffenberg MD, The Children’s Hospital, Denver
New therapies Alessio Fasano MD, University of Maryland
C Oral Abstract Presentations
Program Description:
This year's meeting will highlight a multidisciplinary approach to pediatric gastroenterolgy, hepatology and nutrition-related problems. Selected topics include advocacy for children with Inflammatory Bowel Disease, Treatment of IBD with Biologics, Fatty Liver Disease, Intestinal Failure, Functional Abdominal Pain, Failure to Thrive, Vitamin D and Inflammation.
Concurrent sessions on Gastrostomy Tubes, NP postgraduate educational requirements, Endoscopy and Interpretation of lab (liver) tests will be presented. We will also have case presentations (Zebras) by social workers, physician assistants, dieticians, occupational therapists and nurses as well as abstract presentations.
We will hold an allied health professionals networking luncheon for all attendees and a social event to celebrate APGNN's 20th Anniversary.
FRIDAY, NOVEMBER 13, 2009
8:15am–9:00am KEYNOTE ADDRESS: ADVOCACY FOR CHILDREN WITH INFLAMMATORY BOWEL DISEASE Jennifer Jaff, Esq.
9:00am–9:40am BIOLOGICS AND BEYOND Athos Bousvaros MD
9:40am–10:00am BREAK
11:45am–1:00pm NETWORKING LUNCHEON
2:15pm–2:30pm BREAK
2:30pm–4:00pm DIFFERENT POINTS OF VIEW: INTERESTING CASES PRESENTED BY MULTIPLE DISCIPLINES Moderator: Mary Alice Tully, MSN, PNP-BC
Amanda Leonard, MPH, RD, CDE Jody Weckwerth, PA Janice Tendler, RN, MS, CPNP Saundra Carpenter, RN Janice Arnold, LICSW Linda Schuberth, MA, OTR/L, SCFES
4:30pm COMMITTEE MEETINGS
13
8:00am BREAKFAST/REGISTRATION
8:15am–9:45am FAILURE TO THRIVE LeAnne Vitito, MS, APRN, CGRN Jenifer Hampsey, MS, RD, CSP Maureen Lefton-Greif, PhD, CCC-SLP, BRS-S
9:45am–10:00am BREAK
10:00am–10:45am VITAMIN D, IBD AND INFLAMMATION Helen Pappa MD
10:45am–12:00pm POSTER PRESENTATIONS
AWARD PRESENTATIONS Poster of Distinction Award CDHNF/APGNN M. Susan Moyer Nursing Research Award APGNN Excellence in Education Award APGNN Excellence in Mentoring Award APGNN Newsletter Award
12:00pm–2:00pm NASPGHAN BUSINESS LUNCH
2:00pm–3:30pm INTESTINAL FAILURE (JOINT SESSION WITH NASPGHAN) Moderator: Stuart Kaufman MD
3:30pm–4:00pm BREAK
4:00pm–5:00pm CONCURRENT SESSIONS
1. NP ROUNDTABLE Moderator: Robin Shannon, MSN, RNC, PNP Discussion of New Educational Requirements Sharon Dudley-Brown, PhD & Jennifer Hill, DNP, ARNP
2. GASTROSTOMY TUBES Susanne Johnson, MSN, APRN
3. ENDOSCOPY ROUNDTABLE Lisa Heard, BSN, RN, CGRN
4. INTERPRETATION OF LAB (LIVER)TESTS TBA
14
REGISTRATION FORM
November 12–14 , 2009 Early-Bird Registration Deadline: August 1, 2009
(To receive Early-Bird rates, envelopes must be postmarked no later than August 1, or standard rates will apply) After August 1st, Standard Rates are applicable. Fees for Postgraduate Course and Annual Meeting will increase by $50
per category. Register on-line at (www.naspghan.org) Please fill in below information completely. Address must indicate where registration/meeting material should be sent.
First Name Last Name
NASPGHAN Postgraduate Course (Thursday, November 12, 2009)
Check your member type Early Bird Rates Standard Rates Amount owed Deadline 8/1/09** Deadline 9/14/09
Member A $300 $350
Non-member B $400 $450
Allied Health Professional G $225 $275
Student / Resident H $75 $125
** To receive Early-Bird rates, envelopes must be postmarked no later than August 1, or standard rates will apply
NASPGHAN Postgraduate Course Learning Lunches(Select One) (Thursday, November 12, 2009) You must be registered for the PG Course to attend a Learning Lunch
Learning Lunches ($50) Amount owed See Page 6 for titles and indicate by number below
First Choice:
Second Choice:
Third Choice:
NASPGHAN Annual Meeting (November 12–14, 2009)
Check your member type Early Bird Rates Standard Rates Amount owed Deadline 8/1/09** Deadline 9/14/09
Member I $325 $375
Non-member J $500 $550
Allied Health Professional O $275 $325
Student / Resident P $75 $125
** To receive Early-Bird rates, envelopes must be postmarked no later than August 1, or standard rates will apply
Additional Events (Friday, November 13 & Saturday, November 14, 2009) Indicate all choices Fee Amount owed
Billing and Coding (Saturday) U No Charge
Meet the Professor Breakfast W1 $40 (Friday) See Page 8 Indicate Choice Below
Meet the Professor Breakfast W2 $40 (Saturday) See Page 10 Indicate Choice Below
Extra Tickets for Saturday X $75Social (Adults)
Extra Tickets for Saturday Y $20Social (Child)
TOTAL $
Meet the Professor Breakfast Sessions (Friday, November 13 & Saturday, November 14, 2009) See page 8 (Friday Sessions) or page 9 (Saturday Sessions) and indicate choices BY NUMBERS below
Friday, November 13, 2009 Saturday, November 14, 2009
First Choice: First Choice:
Second Choice: Second Choice:
Third Choice: Third Choice:
Payment Information: MasterCard Visa
Credit Card #:_______________________________________Verification Code #:_________ Expiration Date:_________________
Make checks (drawn on a US bank in US funds) payable to NASPGHAN (Mail or Fax completed form to): NASPGHAN / PO Box 6 / Flourtown, PA 19031 Fax: 215-233-3918
Contact NASPGHAN National Office if further information is needed Phone: 215-233-0808 / Fax: 215-233-3918 / [email protected] / www.naspghan.org
NASPGHAN ID 84-126-4996
NASPGHAN Postgraduate Course – Registration fees include Postgraduate course syllabus, continental breakfast, and coffee breaks
NASPGHAN Annual Meeting – Registration fees for the Annual Meeting include the wine and cheese reception on Thursday evening, continental breakfast on Saturday morning, lunch on Friday and Saturday, coffee breaks, and the Social event on Saturday evening.
Cancellation and Refund:
Requests for refunds must be submitted in writing and be received in the National Office by October 14, 2009. No refund requests will be accepted after that date. Registration badge and receipt must accompany request. Approved refunds will be issued after the meeting.
Booth Selection (NASPGHAN reserves the right to rearrange the floor plan or relocate displays)
17
Dear Colleague: We invite you to attend The NASPGHAN Annual Meeting & Postgraduate Course to be held at the beautiful Gaylord National Hotel in National Harbor, MD from Thursday through Saturday November 12th –14th, 2009. The planning committee, including B Li, John Barnard, John Pohl, Steven Schwarz, Alan Leichtner, David Rudnick, Mitch Shub and Kathy Schwarz, has put together an outstanding program that will engage the interest of clinicians, academics, and trainees alike.
The NASPGHAN meeting will begin on Thursday November 12th, 2009 with the annual NASPGHAN Postgraduate Course. We will review a broad spectrum of pediatric gastrointestinal physiology and disease, testing, and treatment modalities. Five topics will be available for this year’s course including obesity management, advances in pediatric hepatobiliary disease, gastrointestinal inflammation, treatment of functional abdominal pain, and new diagnostic testing. Fifteen speakers from North America who are experts in pediatric gastroenterology will present in-depth discussions of these subjects, and we will have one-hour learning lunches in which these speakers will present patient cases.
The main portion of the NASPGHAN meeting begins the evening of Thursday November 12th with a poster session and reception and concludes Saturday evening with a social event. An outstanding and diverse faculty has been assembled for the meeting which will include two distinguished invited speakers: Dr. Preston Campbell of the Cystic Fibrosis Foundation and Dr. Stephen James, Director of the NIDDK, state-of-the-art, year-in-review formats (for both clinical and basic science), 6 research abstract oral presentations and 3 poster sessions (covering basic science, clinical investigation, and clinical practice vignettes and including oral presentations of 6 Posters of Distinction on Friday and Saturday), four concurrent clinical modules will include two new initiatives: a “virtual” Hepatitis B session with 5 small discussion groups and a multi-disciplinary team approach to the management of intestinal failure. The clinical modules have been redesigned to include a 30-minute case-based panel and audience discussion.
Indeed, this year’s NASPGHAN Meeting will be a fabulous event, sure to meet the multiple clinical, research and training needs of our diverse membership.
We look forward to seeing you in our nation’s capital!
Cordially,
B Li, MD Kathleen Schwarz, MD President, NASPGHAN President-Elect, NASPGHAN
ORGANIZING COMMITTEE B Li, MD (NASPGHAN President) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Program Advisor
David Gremse, MD (NASPGHAN Secretary-Treasurer) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Meeting budget
Sandeep Gupta, MD (Professional Education Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Postgraduate Course, Co-Director
Alan Leichtner, MD (Chair, Training Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Teaching and Tomorrow Program
Jenifer Lightdale, MD (Chair, Endoscopy Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Video Learning Center
NASPGHAN National Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Meeting oversight, logistics, planning
John Pohl, MD (Chair, Professional Education Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Postgraduate Course, Co-Director
David Rudnick, MD (Chair, Research Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Annual Meeting
Kathleen Schwarz, MD (NASPGHAN President-Elect) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Program Committee Chair
Steven Schwarz, MD (Chair, Clinical Care & Quality Committee) . . . . Clinical Practice Forum, Clinical Vignette Posters, Billing & Coding
Mitchell Shub, MD (Chair, Professional Development Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Annual Meeting
Located just eight miles due south of Washington, DC, with convenient access to three major airports, the resort hotel is just 15 minutes away from our nation's capital. Located in National Harbor, Maryland in Prince George's County, Gaylord National offers its guests convenient access to Washington, DC with an hourly shuttle service, water taxi to Old Town Alexandria, and shuttle service to Ronald Reagan National Airport.
HOTEL INFORMATION
GAYLORD NATIONAL® Convention Center 201 WATERFRONT STREET NATIONAL HARBOR, MD 20745
HOTEL RESERVATIONS
Single/Double $239.00 + $15.00 Daily Resort Fee* *Includes: in-room high speed internet access, local phone calls up
to 20 minutes, wireless internet access in atrium, lobby & restaurants, toll-free phone calls up to 20 minutes, access to fitness center, two bottled waters in guest room daily and a daily newspaper.
Special NASPGHAN room rate. Applicable taxes will be added. (US rate subject to change based on current exchange rates)
Check-in Time 3:00pm
Check-out Time 12:00noon
To obtain the special NASPGHAN room rates, register ONLINE via the NASPGHAN website:
www.naspghan.org
REGISTRATION The DEADLINE for Early Bird Registration is August 1, 2009
To receive Early-Bird rates and submitting payment by check, envelope must be postmarked no later than August 1, or standard rates will apply.
After August 1st, Standard Rates are applicable. Fees for Postgraduate Course and Annual Meeting will increase by $50 per category.
The DEADLINE for Standard Registration is September 14, 2009
To receive Standard rates and submitting payment by check, envelope must be postmarked no later than September 14, 2009, or On-site registration rates will apply.
After September 14th, On-site Rates are applicable. Fees for Postgraduate Course and Annual Meeting will increase by $50 per category.
Register by mail, fax or Internet. Visit www.naspghan.org to register online. Alternately, mail or fax the registration form located on pages 15–17 of this brochure to the NASPGHAN National Office. Meeting confirmations, tickets and badges will be mailed 3 weeks prior to the meeting.
MEETING OBJECTIVES AND CME INFORMATION Mission Statement
The education mission of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition is to:
Advance understanding of normal development, physiology and pathophysiology of diseases of the gastrointestinal tract, liver and nutrition in children.
Improve professional competence, quality of care, and patient outcomes by disseminating knowledge through scientific meetings, professional and public education.
Our activities, education, and interventions will strive to use Adult Learning Methods (ALM) designed to improve competence, practice performance, and patient outcomes in measurable ways. These educational activities will be targeted to board certified or board eligible pediatric gastroenterologists, physicians with an expertise in pediatric gastroenterology, hepatology and nutrition, subspecialty fellows in pediatric gastroenterology, and nurses specializing in pediatric gastroenterology, hepatology and nutrition.
CME INFORMATION NASPGHAN is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NASPGHAN designates this educational activity for a maximum of 27.25 AMA PRA Category 1 Credit(s) TM. (7.25 credit hours for the Postgraduate Course and 20.0 credit hours for the Annual Meeting). Physicians should only claim credit commensurate with the extent of their participation in the activity.
FACULTY DISCLOSURE In order to ensure independence, objectivity and scientific rigor in all activities and in accordance with the ACCME, ANCC and ACPE Standards for Commercial Support, all those in a position to control the content of an educational activity are required to disclose their relevant financial relationships. This includes indicating that one has nothing to disclose. Disclosure information will be distributed to the activity attendees.
AMERICANS WITH DISABILITIES ACT In compliance with the Americans with Disabilities Act of 1990, NASPGHAN will make all reasonable effort to accommodate persons with disabilities. Contact NASPGHAN in order to make arrangements.
NASPGHAN National Office PO Box 6 Flourtown, PA 19031
Telephone: 215-233-0808 Fax: 215-233-3918 Email: [email protected] Website: www.naspghan.org
8:00am–8:10am INTRODUCTION
Course Directors: John Pohl MD and Sandeep Gupta MD
8:10am–9:20am MODULE A – Obesity: What Can We Do In The Office?
Moderators: John Pohl MD and Kathy Chen MD
Evaluating obesity: Where do I start? Ann Scheimann MD, Johns Hopkins School of Medicine
LEARNING OBJECTIVES:
1. Discuss how the obese child should be evaluated for complications in the office setting, including the use of laboratory testing 2. Define metabolic syndrome and its instability as a diagnosis 3. Discuss current trials and possible use of medication, combined with lifestyle change, including metformin and
thiazolidinediones for treatment of steatohepatitis in association with metabolic syndrome
Increasing activity: What can we do? Sarah Barlow MD, Texas Children’s Hospital
LEARNING OBJECTIVES:
1. Summarize the determinants of increasing patient activity, including behavior change and family-based changes 2. Discuss the role of city/community exercise programs and exercise camps in obesity management 3. Outline billing and insurance aspects regarding these methods of weight reduction
Behavioral therapy and obesity Joseph Skelton MD, Wake Forest University
LEARNING OBJECTIVES:
1. Discuss the role of behavioral modification in obesity management and include strategies to improve clinician-family interaction 2. Review the effectiveness of group visits to treat pediatric obesity 3. Describe other psychological tools, including motivational interviewing and readiness for change assessment
9:10am–9:20am Rapid Fire Questions
9:20am–10:30am MODULE B – Advances in Pediatric Liver Disease: How Do We Interpret the Data?
Moderators: John Pohl MD and Vicky Ng MD
Alagille syndrome: Update Binita Kamath MD, Children’s Hospital of Philadelphia
LEARNING OBJECTIVES:
1. Define Alagille syndrome and update the extra-hepatic manifestations of this syndrome 2. Discuss genetic testing and potential pre-natal testing for Alagille syndrome, including JAG1 and NOTCH2 mutations 3. Review the potential role of cholestatic disease research consortia in the development of future diagnostic testing and therapy
4
Mitochondrial liver disease: Amping up the liver Ronald Sokol MD, University of Colorado
LEARNING OBJECTIVES:
1. Discuss the clinical presentations and genetics, including extra-hepatic involvement, of mitochondrial liver disease 2. Review current testing techniques (serum, hepatic tissue, muscle tissue, CNS imagine, DNA testing, etc.) for mitochondrial
liver disease 3. Discuss pros and cons of liver transplantation in mitochondrial diseases
Primary sclerosing cholangitis: Update Girish Subbarao MD, Indiana University
LEARNING OBJECTIVES:
1. Discuss the pathophysiology of PSC and review its extra-hepatic manifestations 2. Discuss the diagnosis of PSC, including liver biopsy, MRCP, and ERCP, especially using these modalities to differentiate PSC
from autoimmune hepatitis 3. Discuss PSC treatment, including high dose versus standard dose ursodeoxycholic acid and liver transplantation
10:20am–10:30am Rapid Fire Questions
10:30am–10:50am BREAK
10:50am–12:00pm MODULE C – Gastrointestinal Inflammation: What is the Natural History of Disease?
Moderators: Sandeep Gupta MD and Miriam Vos MD
Eosinophilic esophagitis: making the eosinophils go away Richard Noel MD, Medical College of Wisconsin
LEARNING OBJECTIVES:
1. Discuss the data available regarding the number of eosinophils per high power field as it relates to treatment 2. Discuss treatment of the pediatric patient in which eosinophilic esophagitis is found incidentally 3. Discuss the natural history of eosinophilic esophagitis as the pediatric patient progresses to adulthood
H. pylori: Should it always be eradicated? Nicola Jones MD, The Hospital for Sick Children, Toronto
LEARNING OBJECTIVES:
1. Discuss the treatment of a child with functional abdominal pain symptoms in which H. pylori is found incidentally 2. Discuss when H. pylori infection should undergo re-testing after a trial of eradication 3. Discuss how a child with H. pylori should be treated if there is no response to therapy
Inflammatory bowel disease and inflammatory markers Aleixo Muise MD, The Hospital for Sick Children, Toronto
LEARNING OBJECTIVES:
1. Discuss what inflammatory markers are associated with severe IBD in children 2. Discuss when genetic mutation testing should be used in children with IBD and discuss potential future genetic testing 3. Discuss if inflammatory markers can change with therapy or with mucosal healing
11:50am–12:00pmRapid Fire Questions
Session 1: Obesity and behavioral therapy
Moderator: Valeria Cohran MD Joseph Skelton MD
Session 2: Primary sclerosing cholangitis/ Elastometry and liver disease
Moderator: Judy O’Connor MD Girish Subbarao MD and Marilyn Siegel MD
Session 3: Alagille syndrome / Mitochondrial liver disease
Moderator: Vicky Ng MD Binita Kamath MD and Ronald Sokol MD
Session 4: Eosinophilic esophagitis / H. pylori infection
Moderator: Miriam Vos MD Richard Noel MD and Nicola Jones MD
Session 5: Biomarkers in IBD / MRI in gastrointestinal disease
Moderator: Kevin Kelly MD Aleixo Muise MD and Ghassan Wahbeh MD
Session 6: Hypnotherapy in irritable bowel syndrome / Inflammation in irritable bowel syndrome
Moderator: Eyad Hanna MD Miranda Van Tilburg PhD and Robert Shulman MD
Session 7: Metabolic syndrome and pharmacology / Exercise and obesity
Moderator: Kathy Chen MD Ann Scheimann MD and Sarah Barlow MD
Session 8: Impedance monitoring / New medical therapies for constipation
Moderator: Melanie Greifer MD Rachel Rosen MD and Rina Sanghavi MD
1:50pm–3:00pm MODULE D – Treatment of Functional Abdominal Pain
Moderators: John Pohl MD and Eyad Hanna MD
Hypnotherapy and irritable bowel syndrome Miranda Van Tilburg PhD, University of North Carolina
LEARNING OBJECTIVES:
1. Discuss how hypnotherapy is a potential therapy for childhood IBS and discuss what specific hypnotherapy techniques can be utilized
2. Discuss the long-term outcome of hypnotherapy as treatment for IBS 3. Review the clinical evidence that hypnotherapy is a potential therapy for childhood IBS as well as an adjunctive use with
medication
6
Irritable bowel syndrome and inflammation Robert Shulman MD, Texas Children’s Hospital
LEARNING OBJECTIVES:
1. Discuss the theorized pathogenesis of inflammation in IBS 2. Discuss studies that have shown a potential association of intestinal inflammation with IBS 3. Discuss antibiotic treatment options for IBS, in the setting of the potential for bacterial overgrowth
New medical therapies for constipation Rina Sanghavi MD, UT-Southwestern
LEARNING OBJECTIVES:
1. Discuss the use of lubiprostone for the treatment of constipation 2. Discuss the potential use of bile acid therapy for treatment of constipation 3. Discuss the potential use of pre- and probiotics for the treatment of constipation
2:50pm–3:00pm Rapid Fire Questions
3:00pm–3:20pm BREAK
3:20pm–4:30pm MODULE E – New Diagnostic Modalities for Gastrointestinal Disease
Moderators: Sandeep Gupta MD and Melanie Greifer MD
Impedance monitoring for GERD Rachel Rosen MD, Children’s Hospital, Boston
LEARNING OBJECTIVES:
1. Discuss how impedance monitoring works and how it can be combined with esophageal pH testing 2. Discuss how impedance techniques can be used in evaluation of esophageal swallowing function 3. Discuss the pediatric data available regarding esophageal impedance studies
Elastometry imaging techniques of the liver Marilyn Siegel MD, Washington University, St. Louis
LEARNING OBJECTIVES:
1. Discuss how elastometry is utilized in imaging as an alternative to liver biopsy 2. Discuss the use of elastometry compared to other invasive or non-invasive biomarkers in the diagnosis of fibrosis/cirrhosis 3. Discuss the use of elastometry in the evaluation of specific liver diseases, such as NAFLD or liver disease associated with
congenital heart disease
LEARNING OBJECTIVES:
1. Review the advantages and disadvantages of MRI compared to other types of abdominal imaging 2. Discuss medical radiation exposure and its associated effects in children with IBD and how this risk is alleviated with MRI 3. Discuss how MRI can be used to diagnose intestinal/pelvic disease, including inflammatory bowel disease and its complications
4:20pm–4:30pm Rapid Fire Questions
7
5:00pm–7:00pm Welcome Reception/Poster Session I
Friday, November 13, 2009 7:00am–8:00am Meet the Professor Breakfasts (registration required)
1 Developmental biology research and pediatric gastrointestinal diseases Robert Heukeroth MD,Washington University and Alan Mayer MD, Medical College of Wisconsin
2 Treatment of HCV Jean Molleston MD, Indiana University and Girish Subbaro MD, Indiana University
3 The difficult IBD patient Carmen Cuffari MD, Johns Hopkins School of Medicine and Ryan Carvalho MD, Nationwide Children's Hospital
4 Liver Disease in Inflammatory Bowel Disease Dennis Black MD, Le Bonheur Children's Hospital and Tamir Miloh MD, Mt. Sinai School of Medicine
5 Controversies in nutrition Maria Mascarenhas MD, Children’s Hospital of Philadelphia and Susanna Huh MD, Children’s Hospital, Boston
6 Functional Abdominal Pain: How much testing is really needed? Samuel Nurko MD, MPH, Children’s Hospital Boston and Bruno Chumpitazi MD, Texas Children’s Hospital
7 The GERD eQipp module and maintenance of certification Jenifer Lightdale MD, Children’s Hospital Boston and Suzanne Nelson MD, Northwestern University
7:00am–8:30am Clinical trials in pediatric gastroenterology
Patricia Robuck PhD, National Institute of Diabetes and Digestive and Kidney Diseases
8:30am–10:00am Plenary Session I
Basic Science: Year in Review Eric Sibley MD, Stanford University, Editor, JPGN
Award winning abstract presentations
Keynote Address–Building the CF Foundation Therapeutics Development Program: Lessons Learned Preston Campbell MD, Executive Vice President for Medical Affairs, Cystic Fibrosis Foundation, Bethesda, MD
10:00am–10:30am Break
10:30am–12:00pm Concurrent Session I
A Virtual Hepatitis B Moderators: Maureen Jonas MD, Karen Murray MD, Michael Narkewicz MD, Barbara Haber MD, Regino Gonzalez-Peralta MD
Treatment of Hepatitis B Kathleen Schwarz MD, Johns Hopkins School of Medicine
New Format–Kathy Schwarz will present a talk on the treatment of children with hepatitis B. In order to facilitate small group discussion the talk will be broadcast into 5 small rooms to accommodate up to 30 persons each. A moderator skilled in the treatment of hepatitis B, will lead a question and answer session related to the virtual presentation. This is an experiment so feedback is encouraged!
B Pancreatitis Moderators: Peter Durie MD and Sohail Husain MD
Pancreatitis in childhood: Why, oh why? Veronique Morinville MD, Montreal Children's Hospital
Acute pancreatitis: Dogmas and myths Mark Lowe MD, Children's Hospital of Pittsburgh of UPMC
Chronic pancreatitis: Roadblocks on the long and windy road Patrick Okolo MD, Johns Hopkins University
C Research Interest Group/Oral Abstract Presentations Moderators: Robert Heukeroth MD and Elyanne Ratcliffe MD
Can Hirschsprung disease be prevented? New ideas from basic research Robert Heukeroth MD, Washington University
12:15pm–2:15pm Poster Session II
2:30pm–4:00pm Concurrent Session II
A Acute Liver Failure Moderators: Will Treem MD and Kathleen Campbell MD
Recognition/referral Robert Squires MD, Children's Hospital of Pittsburgh of UPMC
Management Philip Rosenthal MD, University of California, San Francisco
Outcomes Estella Alonso MD, Children's Memorial Hospital, Chicago
B Gastrointestinal bleeding in pediatric patients: Why it happens and how to make it stop Moderators: Marsha Kay MD and Mark Gilger MD
Etiologies of GI bleeding in children Jenifer Lightdale MD, Children’s Hospital, Boston
Medical management for upper gastrointestinal bleeding Khalid Khan MD, University of Minnesota
Endoscopic therapy for UGI bleeding Douglas Fishman MD, Texas Children’s Hospital
C Oral Abstract Presentations
Moderators: Steve Schwarz MD and Ian Leibowitz MD
Productivity and performance in pediatric GI practice: A view from the dentist's chair Speakers: Michael Hart MD, Kathleen Mueller and Robert Squires MD
6:00pm–8:00pm Training Program Directors Meeting
Saturday, November 14, 2009
7:00am–8:00am Meet the Professor Breakfasts (Registration Required)
1 Translational research in pediatric gastroenterology James Heubi MD Cincinnati Children’s Hospital & Medical Center and Glenn Furuta MD, The Children’s Hospital, Denver
2 Psychological issues of IBD Eva Szigethy MD, PhD, Children’s Hospital, Boston and Christine Karkowski MD, Children's Hospital of Pittsburgh of UPMC
3 Food allergy Philip Putnam MD, Cincinnati Children’s Hospital & Medical Center and J Pablo Abonia MD, Cincinnati Children’s Hospital & Medical Center
4 GI infections Michael Farrell MD, Cincinnati Children’s Hospital & Medical Center and Sean Moore MD, Vanderbilt Children’s Hospital
5 Endoscopic research Bradley Barth MD, Children’s Medical Center of Dallas and Tom Lin MD, Duke University Medical Center
6 Animal models of inflammatory bowel disease Ted Denson MD Cincinnati Children’s Hospital & Medical Center and Edwin De Zoeten MD, Children’s Hospital of Philadelphia
7:00am–8:30am IBD research: A guide for fellows and junior faculty
1 Subra Kugathasan MD, Emory University
2 Ying Lu MD, Children’s Hospital, Boston
3 Athos Bousvaros MD, Children’s Hospital, Boston
4 Michael Kappelman MD, University of North Carolina
5 Marjorie Merrick, Crohn's & Colitis Foundation of America
6 Sandra Kim MD, Crohn's & Colitis Foundation of America
10
8:30am–10:00am Plenary Session II
Clinical Science: Year in Review William Balistreri MD, Cincinnati Children’s Hospital and Medical Center, Editor, Pediatrics
Maintenance of Certification and Quality Improvement Chris Dickinson MD, American Board of Pediatrics Richard Colletti MD, Trailblazer Improvement Collaborative
Oral Abstract Presentations
Moderators: Harpreet Pall MD and Leo Heitlinger MD Kathleen Mueller
10:00am–12:00pm Poster Session III
12:00pm–2:00pm Annual Business Meeting/Lunch
Keynote Address–NIDDK Support of Research in Pediatric Gastroentology, Hepatology and Nutrition Stephen James MD, Director of The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2:00pm–3:30pm Concurrent Session III
A Guidelines Moderators: Steven Schwarz MD and Pamela Brown MD
Probiotics David Mack MD, Children's Hospital of Eastern Ontario
Neurodevelopmental Kay Motil MD, Baylor University
Skeletal health and IBD Helen Pappas MD, Children’s Hospital, Boston
B Intestinal Failure: The importance of a team approach to problem solving from intestinal rehabilitation to transplantation and beyond Moderator: Stuart Kaufman MD
Intestinal Rehabilitation Surgeon Alfred Chahine MD, Georgetown University School of Medicine
Nurse Coordinator Jill I. Robinson RN, BSN, PNP, Georgetown University School of Medicine
Nutritionist Paige Parady RD, Georgetown University School of Medicine
Pediatric Gastroenterologist Team Leader Stuart S. Kaufman MD, Georgetown University School of Medicine
Social Worker Carrie Potoff MSW, LICSW, Georgetown University School of Medicine
Surgical Nurse Coordinator Martha Kossairas RN, BSN, Georgetown University School of Medicine
Transplant Surgeon Cal S. Matsumoto MD
C Oral Abstract Presentations
3:45pm–5:15pm Concurrent Session IV
A IBD – Biologics Moderators: Athos Bousvaros MD and Maria Oliva–Hemker MD
TNF Inhibitors: Update on efficacy and safety Wallace Crandall MD, Nationwide Children’s Hospital
When should you consider early use of biologics? Joel Rosh MD, Goryeb Children’s Hospital
Beyond TNF Inhibitors: New biologics and the new wave of IBD therapeutics Robert Baldassano MD, Children’s Hospital of Philadelphia
B Celiac Disease Moderators: Alan Leichtner MD and Murali Jatla MD
Diagnosis/Markers Ivor Hill MD, Wake Forest University
Long term complications Ed Hoffenberg MD, The Children’s Hospital, Denver
New therapies Alessio Fasano MD, University of Maryland
C Oral Abstract Presentations
Program Description:
This year's meeting will highlight a multidisciplinary approach to pediatric gastroenterolgy, hepatology and nutrition-related problems. Selected topics include advocacy for children with Inflammatory Bowel Disease, Treatment of IBD with Biologics, Fatty Liver Disease, Intestinal Failure, Functional Abdominal Pain, Failure to Thrive, Vitamin D and Inflammation.
Concurrent sessions on Gastrostomy Tubes, NP postgraduate educational requirements, Endoscopy and Interpretation of lab (liver) tests will be presented. We will also have case presentations (Zebras) by social workers, physician assistants, dieticians, occupational therapists and nurses as well as abstract presentations.
We will hold an allied health professionals networking luncheon for all attendees and a social event to celebrate APGNN's 20th Anniversary.
FRIDAY, NOVEMBER 13, 2009
8:15am–9:00am KEYNOTE ADDRESS: ADVOCACY FOR CHILDREN WITH INFLAMMATORY BOWEL DISEASE Jennifer Jaff, Esq.
9:00am–9:40am BIOLOGICS AND BEYOND Athos Bousvaros MD
9:40am–10:00am BREAK
11:45am–1:00pm NETWORKING LUNCHEON
2:15pm–2:30pm BREAK
2:30pm–4:00pm DIFFERENT POINTS OF VIEW: INTERESTING CASES PRESENTED BY MULTIPLE DISCIPLINES Moderator: Mary Alice Tully, MSN, PNP-BC
Amanda Leonard, MPH, RD, CDE Jody Weckwerth, PA Janice Tendler, RN, MS, CPNP Saundra Carpenter, RN Janice Arnold, LICSW Linda Schuberth, MA, OTR/L, SCFES
4:30pm COMMITTEE MEETINGS
13
8:00am BREAKFAST/REGISTRATION
8:15am–9:45am FAILURE TO THRIVE LeAnne Vitito, MS, APRN, CGRN Jenifer Hampsey, MS, RD, CSP Maureen Lefton-Greif, PhD, CCC-SLP, BRS-S
9:45am–10:00am BREAK
10:00am–10:45am VITAMIN D, IBD AND INFLAMMATION Helen Pappa MD
10:45am–12:00pm POSTER PRESENTATIONS
AWARD PRESENTATIONS Poster of Distinction Award CDHNF/APGNN M. Susan Moyer Nursing Research Award APGNN Excellence in Education Award APGNN Excellence in Mentoring Award APGNN Newsletter Award
12:00pm–2:00pm NASPGHAN BUSINESS LUNCH
2:00pm–3:30pm INTESTINAL FAILURE (JOINT SESSION WITH NASPGHAN) Moderator: Stuart Kaufman MD
3:30pm–4:00pm BREAK
4:00pm–5:00pm CONCURRENT SESSIONS
1. NP ROUNDTABLE Moderator: Robin Shannon, MSN, RNC, PNP Discussion of New Educational Requirements Sharon Dudley-Brown, PhD & Jennifer Hill, DNP, ARNP
2. GASTROSTOMY TUBES Susanne Johnson, MSN, APRN
3. ENDOSCOPY ROUNDTABLE Lisa Heard, BSN, RN, CGRN
4. INTERPRETATION OF LAB (LIVER)TESTS TBA
14
REGISTRATION FORM
November 12–14 , 2009 Early-Bird Registration Deadline: August 1, 2009
(To receive Early-Bird rates, envelopes must be postmarked no later than August 1, or standard rates will apply) After August 1st, Standard Rates are applicable. Fees for Postgraduate Course and Annual Meeting will increase by $50
per category. Register on-line at (www.naspghan.org) Please fill in below information completely. Address must indicate where registration/meeting material should be sent.
First Name Last Name
NASPGHAN Postgraduate Course (Thursday, November 12, 2009)
Check your member type Early Bird Rates Standard Rates Amount owed Deadline 8/1/09** Deadline 9/14/09
Member A $300 $350
Non-member B $400 $450
Allied Health Professional G $225 $275
Student / Resident H $75 $125
** To receive Early-Bird rates, envelopes must be postmarked no later than August 1, or standard rates will apply
NASPGHAN Postgraduate Course Learning Lunches(Select One) (Thursday, November 12, 2009) You must be registered for the PG Course to attend a Learning Lunch
Learning Lunches ($50) Amount owed See Page 6 for titles and indicate by number below
First Choice:
Second Choice:
Third Choice:
NASPGHAN Annual Meeting (November 12–14, 2009)
Check your member type Early Bird Rates Standard Rates Amount owed Deadline 8/1/09** Deadline 9/14/09
Member I $325 $375
Non-member J $500 $550
Allied Health Professional O $275 $325
Student / Resident P $75 $125
** To receive Early-Bird rates, envelopes must be postmarked no later than August 1, or standard rates will apply
Additional Events (Friday, November 13 & Saturday, November 14, 2009) Indicate all choices Fee Amount owed
Billing and Coding (Saturday) U No Charge
Meet the Professor Breakfast W1 $40 (Friday) See Page 8 Indicate Choice Below
Meet the Professor Breakfast W2 $40 (Saturday) See Page 10 Indicate Choice Below
Extra Tickets for Saturday X $75Social (Adults)
Extra Tickets for Saturday Y $20Social (Child)
TOTAL $
Meet the Professor Breakfast Sessions (Friday, November 13 & Saturday, November 14, 2009) See page 8 (Friday Sessions) or page 9 (Saturday Sessions) and indicate choices BY NUMBERS below
Friday, November 13, 2009 Saturday, November 14, 2009
First Choice: First Choice:
Second Choice: Second Choice:
Third Choice: Third Choice:
Payment Information: MasterCard Visa
Credit Card #:_______________________________________Verification Code #:_________ Expiration Date:_________________
Make checks (drawn on a US bank in US funds) payable to NASPGHAN (Mail or Fax completed form to): NASPGHAN / PO Box 6 / Flourtown, PA 19031 Fax: 215-233-3918
Contact NASPGHAN National Office if further information is needed Phone: 215-233-0808 / Fax: 215-233-3918 / [email protected] / www.naspghan.org
NASPGHAN ID 84-126-4996
NASPGHAN Postgraduate Course – Registration fees include Postgraduate course syllabus, continental breakfast, and coffee breaks
NASPGHAN Annual Meeting – Registration fees for the Annual Meeting include the wine and cheese reception on Thursday evening, continental breakfast on Saturday morning, lunch on Friday and Saturday, coffee breaks, and the Social event on Saturday evening.
Cancellation and Refund:
Requests for refunds must be submitted in writing and be received in the National Office by October 14, 2009. No refund requests will be accepted after that date. Registration badge and receipt must accompany request. Approved refunds will be issued after the meeting.
Booth Selection (NASPGHAN reserves the right to rearrange the floor plan or relocate displays)
17